About Nicholas Galli
Nicholas Galli is a chief executive officer and director at Alphina Therapeutics.
Experience
This experience comes from Nicholas Galli's profile and from SEC filings. For roles taken from filings, the years are when the filings name Nicholas Galli in the role, so the role may have started earlier or lasted longer.
Alphina Therapeutics, Inc. Current
Chief Executive Officer and director
2024 – Present · New Haven, CT
Develops cancer drugs and a patient-selection test for people with solid tumors.
IT
Interline Therapeutics
Chief Operating Officer
2021 – 2023
CT
CytomX Therapeutics
Chief Business Officer
2019 – 2021
DT
Denali Therapeutics
Vice President of Business Development
2015 – 2019
JC
J&J California Innovation Center
Senior Director, Transactions
2014 – 2015
GE
Genentech
Senior Manager, Business Development
2007 – 2014
WR
Wilson Sonsini Goodrich & Rosati
Associate
2007
SA
Skadden Arps
Associate
2002 – 2007
Key Colleagues at Startups
The people Nicholas Galli works with at each company, as listed on that company's latest Form D.
Alphina Therapeutics, Inc. · Form D, Mar 16, 2026
BF
Barbara Fox
Chair
CC
Colleen Cuffaro
Member of Alphina's Board
KR
Kevin Rakin
Director
MC
Matthew Cohen
Director
RB
Ranjit Bindra
Director